Prame peptide VLDGLDVLL (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
Prame peptide VLDGLDVLL (HLA-A*0201)

Prame(100-108) peptide VLDGLDVLL (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human preferentially expressed antigen in melanoma (Prame) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: VLDGLDVLL
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

CD8 Fab-TACS® Magnetic Microbead Starter Kit, human

CD8 Fab-TACS® Magnetic Microbead Starter Kit, human

IBA Lifescience
Więcej
OVA-Q4H7 peptide SIIQFEHL (H-2 Kb)

OVA-Q4H7 peptide SIIQFEHL (H-2 Kb)

IBA Lifescience
Więcej
MHC I-Strep HLA-B*0702; CMV pp65 (RPHERNGFTVL)

MHC I-Strep HLA-B*0702; CMV pp65 (RPHERNGFTVL)

IBA Lifescience
Więcej